Vaginal Neoplasms

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-02-05
Clinical Trial Update: Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) [Phase 3]
Phase 3 safety and immunogenicity study of GARDASIL 9 (V503) in 9- to 26-year-old females and males in Vietnam has completed enrollment with…